Pleiotropic effects of CXC chemokines in gastric carcinoma: Differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma

Clinical and Experimental Immunology

Volumn 134, Issue 3, 2003, Pages 508-515

  Eck, M ^a,b   Schmausser B ^a   Scheller, K ^a   Brandlein S ^a   Muller Hermelink H K ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

Chemokine receptors; CXC chemokines; Gastric carcinoma

Indexed keywords

ALPHA CHEMOKINE; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CXCR1; CHEMOKINE RECEPTOR CXCR2; CHEMOKINE RECEPTOR CXCR3; CXCL1 CHEMOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MONOKINE; MONOKINE INDUCED BY INTERFERON GAMMA; ONCOPROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; GENE EXPRESSION; GROWTH RELATED ONCOGENE ALPHA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; LYMPHOCYTIC INFILTRATION; MACROPHAGE; PLEIOTROPY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STOMACH CARCINOMA; T LYMPHOCYTE; TUMOR VASCULARIZATION;

EID: 0346751951     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2003.02305.x     Document Type: Article

References (28)

1. Wang JM, Deng X, Gong W et al. Chemokines and their role in tumor growth and metastasis. J Immunol Meth 1998; 220:1-17.
2. Moore BB, Arenberg DA, Addison F et al. Tumor angiogenesis is regulated by CXC chemokines. J Lab Clin Med 1998; 132:97-103.
3. Belperio JA, Keane MP, Douglas AA et al. CXC chemokines in angiogenesis. J Leukoc Biol 2000; 68:1-8.
4. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000; 18:217-42.
5. Strieter RM. Chemokines: not just leukocyte chemoattractants in the promotion of cancer. Nat Immunol 2001; 2:285-6.
6. Kupers H, Adami HO, Trichopoulos S. Infection as a maior preventable cause of human cancer. J Int Med 2000; 248:171-83.
7. Lauren P. The two histopathological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histoclinical classification. Acta Patholog Microbiol Scand 1965; 64:31-49.
8. Luster AD. Chemokines - chemotactic cytokines that mediate inflammation. New Engl J Med 1998; 338:436-47.
9. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines CXC and CC chemokines. Adv Immunol 1994; 55:97-179.
10. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opin Immunol 1994; 6:865-73.
11. Liao BF, Rabin RL, Yannelli JR et al. Human MIG chemokine: biochemical and functional characterization. J Exp Med 1995; 182:1301-14.
12. Loetscher M, Gerber B, Loetscher P et al. Chemokine receptor specific for IP-10 and MIG, structure, function and expression in activated T-lymphocytes. J Exp Med 1996; 184:963-9.
13. Farber JM. MIG and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997; 61:246-57.
14. Remmele W, Stegner HE. Vorschlag zur einheitlichen Definierung eines immunreaktiven Score (IRS) für den immunhistochemischen Östrogenrezeptornachweis (ER-ICA) im Mammakarzinomgewebe. Pathologe 1987; 8:138-40.
15. Weidner N, Semple JP, Welch WR et al. Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
16. Tanigawa N, Amaya H, Matsumura M et al. Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinomas. Cancer Res 1996; 56:2671-6.
17. Smith DR, Polverini PJ, Kunkel SL et al. Inhibition of IL-8 attentuates angiogenesis in bronchogenic carcinoma. J Exp Med 1994; 179:1409-15.
18. Yoneda J, Kuniyasu H, Crispens MA et al. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 1998; 90:447-54.
19. Fujimoto J, Sakaguchi H, Aoki I et al. Clinical implications of expression of interleukin 8 related to angiogenesis in uterine cervical cancers. Cancer Res 2000; 60:2632-5.
20. Inoue K, Slaton JW, Eve BY et al. Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer. Clin Cancer Res 2000; 6:2104-19.
21. Eck M, Schmausser B, Scheller K et al. CXC chemokines Groα/IL-8 and IP-10/MIG in Helicobacter pylori gastritis. Clin Exp Immunol 2000; 122:192-9.
22. Kitadai Y, Takahashi Y, Haruma K et al. Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 1999; 81:647-53.
23. Kitadai Y, Haruma K, Sumii K et al. Expression of interleukin-8 correlates with vascularity in human gastric cancer. Am J Pathol 1998; 152:93-100.
24. Larsen CG, Anderson AO, Appella E et al. The neutrophil-activating protein (NAP-1) is also chemotactic for T lymphocytes. Science 1989; 243:1464-6.
25. Tani K, Su SB, Utsonomiya I et al. Interferon gamma maintains the binding and functional capacity of receptors for IL-8 on cultured human T cells. Eur J Immunol 1998; 28:502-7.
26. Luca M, Huang S, Gershenwald JE et al. Expression of interleukin-8 by human melanoma cells upregulates MMP-2 activity and increases tumor growth and metastasis. Am J Pathol 1997; 151:1105-13.
27. Kitadai Y, Haruma K, Mukaida N et al. Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Canc Res 2000; 6:2735-40.
28. Mayer B, Johnson JP, Leitl F et al. E-Cadherin expression in primary and metastastic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 1993; 53:1690-5.